SidoMuncul eyes $131m IPO in Q4
Indonesian herbal medicine producer, SidoMuncul, is planning a Rph1.5tr ($131m) IPO in the fourth quarter, according to a source close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts